Literature DB >> 17201026

Panitumumab.

Leonard Saltz, Chris Easley, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17201026     DOI： 10.1038/nrd2204

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  21 in total

1.  Trial Watch: Monoclonal antibodies in cancer therapy.

Authors:  Lorenzo Galluzzi; Erika Vacchelli; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Jessica Zucman-Rossi; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

2.  Panitumumab.

Authors:  Eline A Dubois; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

Review 3.  Omics and therapy - a basis for precision medicine.

Authors:  Joseph P Garay; Joe W Gray
Journal:  Mol Oncol       Date:  2012-03-08       Impact factor: 6.603

Review 4.  Current targeted therapies in the treatment of advanced colorectal cancer: a review.

Authors:  Andrew Moriarity; Jacintha O'Sullivan; John Kennedy; Brian Mehigan; Paul McCormick
Journal:  Ther Adv Med Oncol       Date:  2016-05-29       Impact factor: 8.168

Review 5.  Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer.

Authors:  Woo-Jeong Jeong; Pu-Hyeon Cha; Kang-Yell Choi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 6.  Targeted nanoagents for the detection of cancers.

Authors:  Jason R McCarthy; Jayeeta Bhaumik; Mark R Karver; S Sibel Erdem; Ralph Weissleder
Journal:  Mol Oncol       Date:  2010-09-08       Impact factor: 6.603

Review 7.  Emerging drugs to treat squamous cell carcinomas of the head and neck.

Authors:  Christopher Fung; Jennifer R Grandis
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

8.  Screening of potential molecular targets for colorectal cancer therapy.

Authors:  Kimi Honma; Ichiro Takemasa; Ryo Matoba; Yusuke Yamamoto; Fumitaka Takeshita; Masaki Mori; Morito Monden; Kenichi Matsubara; Takahiro Ochiya
Journal:  Int J Gen Med       Date:  2009-12-29

9.  Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis.

Authors:  Yongle Pang; Wei-Han Wang; Gavin E Reid; Donald F Hunt; Merlin L Bruening
Journal:  Anal Chem       Date:  2015-10-22       Impact factor: 6.986

10.  Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis.

Authors:  S Q Ashraf; P Umana; E Mössner; T Ntouroupi; P Brünker; C Schmidt; J L Wilding; N J Mortensen; W F Bodmer
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.